CMB International: Raise Ping An Insurance (02318) target price to HK$75, third-quarter profit exceeds expectations.
Excluding one-time non-operating factors, China Ping An's net profit after tax is expected to grow more strongly, with year-on-year increases of 27% and 82% for the first three quarters and the third quarter respectively.
CMB International released a research report stating that considering the improvement in investment income, the reduction of negative impacts from asset management business, and the enhanced synergies within the group, the earnings per share forecast for Ping An Insurance (02318) for 2025 to 2027 has been raised by 9%, 4%, and 5% respectively, to 8 yuan, 8.3 yuan, and 9.2 yuan Chinese currency. The target price has been raised from 71 Hong Kong dollars to 75 Hong Kong dollars, reaffirming a "buy" rating.
Ping An Insurance's net profit in the first three quarters increased by 11.5% year-on-year to 133 billion Chinese currency, and the growth in the third quarter reached 45.4%, exceeding the bank's expectation of 129 billion. Excluding one-time non-operating factors, the after-tax net profit growth will be even stronger, with a year-on-year increase of 27% and 82% in the first three quarters and the third quarter respectively. The new business value (NBV) in the first three quarters increased by 46.2% to 35.7 billion Chinese currency, while in the third quarter it increased by 58.3%, benefiting from the strong growth in agency channels and bank insurance channels.
 Related Articles 

Jilin Quanyangquan (600189.SH) subsidiary wins bid for 148 million yuan aircraft drinking water group purchase project.

Changshu Fengfan Power Equipment (601700.SH) has repurchased a total of 26.8141 million shares, with a total expenditure of 115 million yuan.
.png)
Tianjin Tianyao Pharmaceuticals' subsidiary Compound Potassium Dihydrogen Phosphate Injection passed the consistency evaluation of generic drugs.
Jilin Quanyangquan (600189.SH) subsidiary wins bid for 148 million yuan aircraft drinking water group purchase project.

Changshu Fengfan Power Equipment (601700.SH) has repurchased a total of 26.8141 million shares, with a total expenditure of 115 million yuan.

Tianjin Tianyao Pharmaceuticals' subsidiary Compound Potassium Dihydrogen Phosphate Injection passed the consistency evaluation of generic drugs.
.png)





